| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0007500 | Intron-Intron | chr16:68157337-68158727 | chr16:68123434-68124824 | 1391 nt | 0.4766 |
| hsa_NFATC3_0007600 | Intron-Exon-Intron | chr16:68159841-68160513 | chr16:68125938-68126610 | 169 nt | 0.4556 |
| hsa_chr16_0275400 | Intergenic-Intergenic | chr16:68160018-68160902 | chr16:68126115-68126999 | 885 nt | 0.3966 |
| hsa_chr16_0275500 | Intergenic-Intergenic | chr16:68160036-68160871 | chr16:68126133-68126968 | 836 nt | 0.3840 |
| hsa_NFATC3_0007700 | Intron-Exon-Intron | chr16:68160315-68217269 | chr16:68126412-68183366 | 141 nt | 0.3830 |
| hsa_NFATC3_0008300 | Intron-Exon-Intron | chr16:68160351-68165930 | chr16:68126448-68132027 | 331 nt | 0.4109 |
| hsa_NFATC3_0008000 | Exon-Exon | chr16:68160351-68172485 | chr16:68126448-68138582 | 235 nt | 0.4383 |
| hsa_NFATC3_0008100 | Exon-Exon | chr16:68160351-68191971 | chr16:68126448-68158068 | 363 nt | 0.4242 |
| hsa_NFATC3_0008400 | Exon-Exon | chr16:68160351-68200918 | chr16:68126448-68167015 | 446 nt | 0.4283 |
| hsa_NFATC3_0008200 | Exon-Exon | chr16:68160351-68208417 | chr16:68126448-68174514 | 677 nt | 0.4136 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].